The global contrast-enhanced ultrasound market is set to experience a groundbreaking phase of growth, with projections indicating a staggering valuation of USD 9,214.3 million by 2033, as revealed by the latest research from Future Market Insights. This anticipated surge highlights a dramatic increase from its 2023 valuation of USD 5,243.3 million, marking a substantial leap from USD 2,700 million in 2022.
The remarkable trajectory of the contrast-enhanced ultrasound market is being driven by a significant rise in demand for lung ultrasonography procedures. This shift reflects a broader transformation in medical imaging preferences, as healthcare providers increasingly adopt advanced ultrasound technologies for more precise diagnostics.
According to Future Market Insights, the market is expected to maintain a robust Compound Annual Growth Rate (CAGR) of 5.8% from 2023 to 2033. This forecast underscores the industry’s ongoing expansion and the growing adoption of contrast-enhanced ultrasound solutions in clinical practice.
Get Your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-10031
Contrast-enhanced ultrasound has emerged as a pivotal asset in medical diagnostics, revolutionizing the precision and efficacy of procedures. Its non-invasive nature, combined with advanced imaging capabilities, has propelled its adoption across various medical domains. The industry is witnessing a rapid uptick in lung ultrasonography procedures, further cementing its position in the medical imaging landscape.
Future Market Insights commented, “This remarkable growth underscores the increasing acceptance and reliance on contrast-enhanced ultrasound in the medical community. Its non-invasive nature, coupled with advanced imaging capabilities, has positioned it as a game-changer in medical diagnostics.”
The Future Market Insights reports offer a comprehensive analysis of the industry’s trajectory, projecting a market valuation of USD 9,214.3 million by the culmination of the decade-long trajectory in 2033. As medical professionals prioritize precision and efficiency in diagnostics, contrast-enhanced ultrasound is poised to play a pivotal role in shaping the future of medical imaging.
Key Takeaways from the Market Study:
- Global contrast-enhanced ultrasound industry grew at a CAGR of 4.7% between 2017 and 2022
- Value of global contrast-enhanced ultrasound industry in 2017 was USD 2,146.0 million
- North America dominates the market and is expected to continue its stronghold for a few more years with a market share of 36.0%, where the United States is expected to hold a major share in the market of 52.4%.
- Japan shares a value of 7.4%. Prospering medical tourism in developing countries such as India growing at a CAGR of 6.9%, Australia at a CAGR of 5.2%, and the Chinese market at 7.7% which further boosts the demand for world-class healthcare services.
- Europe holds a market share of 28.0% whereas the United Kingdom and Germany are said to hold an important part in this region where Germany holds a market share of 7.0% and the United Kingdom is said to grow at a CAGR of 5.1%.
- Targeted type holds a major portion of the market and holds a market share of 59.0%
- Hospitals are said to dominate the market and are projected for a revenue share of 39%
- Demand for echocardiography is said to be faring where echocardiography shares a major portion of the market with a value of 60.13%
Checkout Now to Access Industry Trends: https://www.futuremarketinsights.com/checkout/10031
Competitive Analysis:
Some of the prominent players in the global market are-
- Trivitron Healthcare
- Bracco Diagnostic Inc.
- Koninklijke Philips N.V.
- K. Medical Holding Company, Inc.
- Lantheus Medical Imaging, Inc.
- GE Healthcare
- Daiichi Sankyo Company, Limited
- Bristol-Myers Squibb Company
- Acusphere, Inc.
- Siemens Healthcare GmbH
Some of the important developments of the key players in the market are:
- In June 2023, Acusphere, Inc. announced the signing of a definitive agreement with Cephalon, Inc. to provide $20 million in upfront financing by purchasing a $15 million senior secured convertible note and by paying a $5 million upfront fee for an exclusive worldwide license to AI-525, a preclinical-stage injectable formulation of celecoxib using Acusphere’s proprietary Hydrophobic Drug Delivery System (HDDSTM) technology.
- In April 2023, Bracco Imaging S.p.A., a global leader in diagnostic imaging, and SonoThera, Inc., a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, have entered into an agreement under which Bracco Imaging will provide its cutting-edge gas-filled microbubbles technology platform to SonoThera for use in the development of its novel, ultrasound-guided nonviral gene therapy platform.
A Full Report Analysis: https://www.futuremarketinsights.com/reports/contrast-enhanced-ultrasound-market
Key Segments Profiled in the Contrast-Enhanced Ultrasound Industry Survey:
Type:
- Non-Targeted
- Targeted
Application:
- Hepatic
- Echocardiography
- Cerebrovascular
- Thyroid & Parathyroid
- Gallbladder & Biliary Tree
- Renal
- Prostate
- Pancreatic
- Vascular
- Lymphatic
- Trauma
- Others
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
